Dr. Lewis received his PhD in Biophysics and his MD from Stanford University. He is the former Chair of the Department of Emergency Medicine at Harbor-UCLA Medical Center, Professor of Emergency Medicine at the David Geffen School of Medicine at UCLA, and the Senior Medical Scientist at Berry Consultants, LLC, a group that specializes in innovative clinical trial design. Dr. Lewis’s expertise centers on adaptive and Bayesian clinical trials, including platform trials; translational, clinical, health services and outcomes research methodology; data and safety monitoring boards, and the oversight of clinical trials. Dr. Lewis was elected to membership in the National Academy of Medicine in 2009. Dr. Lewis is a member of the Blood Products Advisory Committee of the US Food and Drug Administration, Center for Biologics Evaluation and Research (CBER) and has served as a member of the Medicare Evidence Development & Coverage Advisory Committee of the Centers for Medicare & Medicaid Services. He has chaired data and safety monitoring boards (DSMBs) for numerous federally-funded, industry-sponsored, and multinational clinical trials. He is a research methodology reviewer for JAMA and an editor of the JAMA series entitled “JAMA Guides to Statistics and Methods.” Dr. Lewis has served as a content reviewer for many other peer reviewed journals. He has authored or coauthored over 270 original research publications, reviews, editorials, and chapters. Dr. Lewis has served as a grant reviewer for the Agency for Healthcare Research and Quality (AHRQ), the Canadian Institutes of Health Research (CIHR), the Centers for Disease Control and Prevention (CDC), the UK Medical Research Council (MRC), the National Cancer Institute of France, the National Institutes of Health (NIH), the Patient Centered Outcomes Research Institute (PCORI), and foundations. During the US COVID-19 epidemic, Dr. Lewis has served as the Director of Covid-19 Demand Modeling for the Los Angeles County Department of Health Services, leading a multidisciplinary team developing epidemiological prediction models to aid in hospital preparedness and response. Dr. Lewis is a Past President of the Society for Academic Emergency Medicine (SAEM) and served on the Board of Directors for the Society for Clinical Trials. He is a fellow of the American College of Emergency Physicians, the American Statistical Association, and the Society for Clinical Trials.
Conflict of Interest